SPRINGWORKS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.63 USD | -0.57% |
|
-2.16% | +14.05% |
| 11-12 | SpringWorks Therapeutics, Inc., Q3 2024 Earnings Call, Nov 12, 2024 | |
| 11-12 | Springworks Therapeutics' Q3 Net Loss Narrows | MT |
Chart calendar SpringWorks Therapeutics, Inc.
f4bca7424cbde704.r5fRMU82UVn8TQSp0TZY-qfyjRjEBoM2EVj3WcvQffk.y9SAQB1XBB7PImfh4nNonMO63lTybtZGYAeHDbnnSbbW_LVEJFwyM5Uccw~72c5fa527fe0f49d5efe3dc0e83563ac
Upcoming events on SpringWorks Therapeutics, Inc.
Past events on SpringWorks Therapeutics, Inc.
| 03/12/2024 17:30 | Evercore ISI HealthCONx Conference |
| 24/11/2024 16:25 | Society for Neuro Oncology Meeting - Abstract #QOL-08 |
| 23/11/2024 01:30 | Society for Neuro Oncology Conference - Abstract #CTNI-20 |
| 23/11/2024 01:30 | Society for Neuro Oncology Conference - Abstract #CTNI-21 |
| 22/11/2024 17:50 | Society for Neuro Oncology Conference - Abstract #CTNI-70 |
| 19/11/2024 15:30 | Jefferies London Healthcare Conference |
| 13/11/2024 18:00 | Guggenheim Securities Healthcare Innovation Conference |
| 12/11/2024 13:30 | Q3 2024 Earnings Call |
| 12/11/2024 11:30 | Q3 2024 Earnings Release |
| 07/08/2024 13:30 | Q2 2024 Earnings Call |
| 07/08/2024 11:30 | Q2 2024 Earnings Release |
| 11/06/2024 19:00 | Goldman Sachs Global Healthcare Conference |
| 03/06/2024 14:00 | American Society of Clinical Oncology Meeting - Abstract Number : 3016 |
| 01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract Number : 11556 |
| 01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract Number : 11558 |
| 31/05/2024 20:45 | American Society of Clinical Oncology Meeting - Abstract Number : 11520 |
| 16/05/2024 14:30 | Annual General Meeting |
| 14/05/2024 23:40 | BofA Securities Health Care Conference |
| 02/05/2024 13:30 | Q1 2024 Earnings Call |
| 02/05/2024 11:30 | Q1 2024 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 5,45 1,01 439.77% | 188 | 355 | 596 |
|
EBITDA Million USD | Released Forecast Spread | -173 -151 -14.43% | -280 -275 -1.8% | -341 -334 -2.28% | -245 | -130 | -128 |
|
EBIT Million USD | Released Forecast Spread | -173 -156 -11.27% | -281 -275 -1.95% | -343 -332 -3.41% | -256 | -159 | -67,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -174 -155 -12.54% | -277 -275 -1.02% | -325 -314 -3.56% | -236 | -145 | -53,7 |
|
Net income Million USD | Released Forecast Spread | -174 -154 -13.22% | -277 -276 -0.54% | -325 -314 -3.41% | -228 | -141 | -24,9 |
|
EPS USD | Released Forecast Spread | -3,59 -3,24 -10.8% | -5,21 -5,25 0.67% | -5,15 -4,92 -4.69% | -3,10 | -2,01 | -0,34 |
| Announcement Date | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 5,45 0,90 502.99% | 21,0 13,1 60.74% | 59,7 34,6 72.74% | 49,3 55,1 -10.59% | 57,1 | 68,7 | 83,2 | 96,5 | 114 |
|
EBITDA Million USD | Released Forecast Spread | -77,4 -84,0 7.8% | -82,5 -79,0 -4.39% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -77,7 -78,9 1.53% | -82,9 -80,0 -3.63% | -84,0 -86,1 2.49% | -98,5 -88,2 -11.68% | -93,9 -88,7 -5.89% | -44,9 -86,3 47.98% | -57,9 -58,7 1.36% | -53,9 | -49,2 | -39,9 | -32,3 | -30,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -87,4 -83,9 -4.1% | -39,9 -83,5 52.19% | -53,5 -52,6 -1.75% | -50,5 | -41,4 | -39,9 | -36,5 | -28,0 |
|
Net income Million USD | Released Forecast Spread | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -87,4 -83,9 -4.1% | -39,9 -83,5 52.19% | -53,5 -52,6 -1.75% | -50,5 | -41,4 | -39,9 | -36,5 | -28,0 |
|
EPS USD | Released Forecast Spread | -1,18 -1,25 5.83% | -1,25 -1,26 0.89% | -1,27 -1,33 4.54% | -1,45 -1,24 -17.2% | -1,18 -1,17 -0.69% | -0,54 -1,12 51.59% | -0,72 -0,75 4.42% | -0,65 | -0,72 | -0,61 | -0,49 | -0,36 |
| Announcement Date | 03/05/23 | 02/08/23 | 02/11/23 | 27/02/24 | 02/05/24 | 07/08/24 | 12/11/24 | - | - | - | - | - |
More events
Past sector events for SpringWorks Therapeutics, Inc.
| 09/12/2024 11:16 | LUMOSA THERAPEUTICS CO., LTD.: November 2024 Sales and Revenue Release |
| 05/12/2024 09:03 | PHARMAESSENTIA CORPORATION: November 2024 Sales and Revenue Release |
| 26/11/2024 21:00 | ARROWHEAD PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 24/11/2024 | ANAVEX LIFE SCIENCES CORP.: Q4 2024 Earnings Release (Projected) |
| 18/11/2024 12:00 | IMMATICS N.V.: Q3 2024 Earnings Release |
| 14/11/2024 21:01 | CELCUITY INC.: Q3 2024 Earnings Release |
| 14/11/2024 21:01 | ASCENDIS PHARMA A/S: Q3 2024 Earnings Release |
| 14/11/2024 13:00 | ANNEXON, INC.: Q3 2024 Earnings Release |
| 14/11/2024 09:09 | PHARMAESSENTIA CORPORATION: Q3 2024 Earnings Release |
| 13/11/2024 | PEPTRON, INC.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SWTX Stock
- Calendar SpringWorks Therapeutics, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition